Company Overview
About Divis Laboratories
Divi’s was established in the year 1990 in Hyderabad, India with two manufacturing units. The laboratory is listed among the top pharmaceutical companies in India. The company is engaged in the manufacture of leading generic compounds and custom synthesis of APIs and intermediates for global innovator companies. The company has four manufacturing facilities and a market presence across several countries.
Founders & Leadership
People Behind Divis Laboratories
Watch
Related video
1 on YouTube · opens in a new tab
Stories & Press Coverage
Divi’s Laboratories Rating ‘Buy’; a strong performance in the second quarter
Divi’s reported a 7/18% beat on Ebitda driven by sustained revenues as well as higher gross contribution. We adjust our FY21 revenues upwards but believe that further gains from the earlier CAPEX round will be gradual.
Divi’s Labs expansion plans raise hopes that its growth will sustain
Big Pharma continues to expand global sourcing, and this has given a great push to the Divi’s Laboratories Ltd stock. The stock has gained 85% this year.
Same sector
